Dexcom (DXCM) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | -7.83% |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 17.54% |
| 10 | Zimmer Biomet Holdings | 18.17 Bn | 17.76 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.05% |
| Mar 31, 2026 | 60.12% |
| Dec 31, 2025 | 42.80% |
| Sep 30, 2025 | 41.02% |
| Jun 30, 2025 | 52.30% |
| Mar 31, 2025 | 2.70% |
| Dec 31, 2024 | 212.86% |
| Sep 30, 2024 | 15.53% |
| Jun 30, 2024 | 22.32% |
| Mar 31, 2024 | 37.35% |
| Dec 31, 2023 | -14.59% |
| Sep 30, 2023 | 18.68% |
| Jun 30, 2023 | 35.78% |
| Mar 31, 2023 | 34.67% |
| Dec 31, 2022 | -0.32% |
| Sep 30, 2022 | 30.25% |
| Jun 30, 2022 | 89.89% |
| Mar 31, 2022 | 77.76% |
| Dec 31, 2021 | 69.10% |
| Sep 30, 2021 | 23.28% |